Efficacy of weekly paclitaxel as single agent chemotherapeutic regimen for patients with advanced urothelial cancer progressing after cisplatin-based chemotherapy, 15-year single center retrospective study

被引：0
|
作者：
Sideris, S. [1 ]
机构：
[1] Jules Bordet, Med Oncol, Brussels, Belgium
来源：
EUROPEAN JOURNAL OF CANCER | 2015年 / 51卷
关键词：
D O I：
10.1016/S0959-8049(16)31432-0
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2614
引用
收藏
页码：S516 / S516
页数：1
相关论文
共 50 条
  • [1] Biweekly paclitaxel and gemcitabine for patients with advanced urothelial cancer ineligible for cisplatin-based regimen
    Takahashi, T
    Higashi, S
    Nishiyama, H
    Segawa, T
    Nakamura, E
    Kinoshita, H
    Itoh, N
    Yamamoto, S
    Kamoto, T
    Habuchi, T
    Ogawa, O
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2006, 36 (02) : 104 - 108
  • [2] Efficacy of weekly paclitaxel treatment as a single agent chemotherapy following first-line cisplatin treatment in urothelial bladder cancer
    Sideris, Spyridon
    Aoun, Fouad
    Zanaty, Marc
    Martinez, Nieves Chanza
    Latifyan, Sofia
    Awada, Ahmad
    Gil, Thierry
    MOLECULAR AND CLINICAL ONCOLOGY, 2016, 4 (06) : 1063 - 1067
  • [3] A single-center retrospective study of a short hydration schedule for cisplatin-based chemotherapy
    Harada, Tomohiko
    Kyotani, Mitutaka
    Ishiyama, Yasushi
    Hattori, Yukako
    Takasaki, Hirotaka
    Sakai, Rika
    Kusuhara, Yoshihiro
    ANNALS OF ONCOLOGY, 2015, 26 : 118 - 118
  • [4] Single Agent Weekly Paclitaxel as Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer: A Feasibility Study
    Gupta, S.
    Bharath, R.
    Shet, T.
    Desai, S. B.
    Patil, V. M.
    Bakshi, A.
    Parmar, V.
    Badwe, R. A.
    CLINICAL ONCOLOGY, 2012, 24 (09) : 604 - 609
  • [5] Efficacy and safety of paclitaxel and gemcitabine combination as the chemotherapy for advanced/metastatic urothelial cancer in a single center in Japan
    Maniwa, Akimitsu
    Kamiyama, Manabu
    Mikami, Yuki
    Furuya, Yasuhisa
    Zakoji, Hidenori
    Tsuchida, Takayuki
    Nomura, Teruhisa
    Fukazawa, Mizuya
    Takihana, Yoshio
    Araki, Isao
    Takeda, Masayuki
    JOURNAL OF UROLOGY, 2008, 179 (04): : 119 - 119
  • [6] Factors that Predict Neutropenia in Korean Patients with Advanced Urothelial Cancer after Cisplatin-Based Systemic Chemotherapy
    Kwon, Whi-An
    Oh, Tae Hoon
    Lee, Jea Whan
    Seo, Ill Young
    Park, Seung Chol
    UROLOGY JOURNAL, 2018, 15 (04) : 168 - 172
  • [7] Comparing the Efficacy of a Triplet Antiemetic Regimen in Patients with Esophageal Cancer and Diabetes Mellitus Treated with Cisplatin-Based Chemotherapy: A Retrospective Study
    Hatori, Masahiro
    Fukuoka, Shota
    Kimura, Shunya
    Kawakami, Kazuyoshi
    Yamaguchi, Kensei
    Yamaguchi, Masakazu
    ONCOLOGY, 2024,
  • [8] The changing use of palliative chemotherapy for recurrent esophagogastric cancer: A single center retrospective 15-year review
    Amonkar S.J.
    Irving M.
    Wayman J.
    Sriram T.
    Griffin S.M.
    Nicoll J.J.
    Raimes S.A.
    Journal of Gastrointestinal Cancer, 2008, 39 (1-4) : 51 - 57
  • [9] Salvage chemotherapy with paclitaxel, ifosfamide, and nedaplatin (pin regimen)in patients with urothelial cancer who have received prior cisplatin-based therapy
    不详
    EUROPEAN UROLOGY SUPPLEMENTS, 2005, 4 (03) : 139 - 139
  • [10] Single-agent Paclitaxel in Advanced Anal Cancer after Failure of Cisplatin and 5-Fluorouracil Chemotherapy
    Abbas, Ali
    Nehme, Elie
    Fakih, Marwan
    ANTICANCER RESEARCH, 2011, 31 (12) : 4637 - 4640
12345